Stock Price Quote

CADILA HEALTHCARE LTD.

NSE : CADILAHCBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE556.0528.75 (+5.45 %)
PREV CLOSE ( ) 527.30
OPEN PRICE ( ) 539.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1368627
TODAY'S LOW / HIGH ( )530.80 568.70
52 WK LOW / HIGH ( )318.1 568.7
NSE556.2529.1 (+5.52 %)
PREV CLOSE( ) 527.15
OPEN PRICE ( ) 542.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 556.25 (428)
VOLUME 28048180
TODAY'S LOW / HIGH( ) 532.65 568.90
52 WK LOW / HIGH ( )318 568.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-05 1995
Management Info
Pankaj R Patel - Chairman Sharvil P Patel - Managing Director
Registered Office

Address Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway,
Ahmedabad,
Gujarat-382481

Phone 079- 26868100 /26868101 /26868102 /26868103 / 04 / 05 / 06 / 07 / 08 / 09 / 10 / 11 / 12 / 13 / 14 / 15 / 16 / 17 / 18 / 19 / 20

Email investor.grievance@zyduscadila.com

Website www.zyduscadila.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, MCX

NEWS

14Apr Cadila Healthcare informs about news p
Cadila Healthcare has informed about news paper publication.The above in..
12Apr Cadila Healthcare gains on the bourses
Cadila Healthcare is currently trading at Rs. 522.00, up by 7.45 points..
08Apr Zydus Cadila gets USFDA's approval to
Zydus Cadila has received final approval from the USFDA to market Macite..
08Apr Cadila Healthcare informs about press
Cadila Healthcare has informed that it has enclosed a copy of press rele..
08Apr Cadila Healthcare surges on the BSE
Cadila Healthcare is currently trading at Rs. 474.10, up by 12.85 points..

Financials

in Millions
QTR Dec 20 ANNUAL 20
Net Profit140314129
Gross Profit 2069 15577
Operating Profit 523122725
Net Sales 1918863474

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  3905.70 (8.77%)
M.Cap ( in Cr)9764.25
Neuland Laboratories (BSE)
peergroup  2674.85 (7.69%)
M.Cap ( in Cr)3431.80
Dr. Reddys Lab (BSE)
peergroup  5153.95 (3.69%)
M.Cap ( in Cr)85710.82
Abbott India (BSE)
peergroup  14860.60 (1.08%)
M.Cap ( in Cr)31577.74
Pfizer (BSE)
peergroup  5480.60 (2.86%)
M.Cap ( in Cr)25072.50

Shareholding Pattern

NON-INSTITUTION 8.4%
PROMOTERS 74.88%
MUTUAL FUNDS/UTI 6.41%
FI/BANKS/INSURANCE 4.71%
GOVERNMENT 0.19%
FII 0%

About Cadila Healthcare Ltd.

Cadila Healthcare Ltd. was incorporated in the year 1995. Its today's share price is 556.05. Its current market capitalisation stands at Rs 56925.21 Cr. In the latest quarter, company has reported Gross Sales of Rs. 68497 Cr and Total Income of Rs.77023 Cr. The company's management includes Dhaval N Soni, Apurva S Diwanji, Dharmishta N Raval, Nitin R Desai, Bhadresh K Shah, Mukesh M Patel, Ganesh N Nayak, Sharvil P Patel, Pankaj R Patel.

It is listed on the BSE with a BSE Code of 532321 , NSE with an NSE Symbol of CADILAHC and ISIN of INE010B01027. It's Registered office is at Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar HighwayAhmedabad-382481, Gujarat. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, Mukesh M Shah & Co, RR Patel & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)